Invega Sustenna 150 mg Injection - Long-Acting Antipsychotic for Schizophrenia

Invega Sustenna 150 mg Injection

Invega Sustenna 150 mg Injection is a long-acting antipsychotic medication used primarily for the treatment of schizophrenia. It contains paliperidone, which helps in managing symptoms such as hallucinations and delusions. This injection is administered under the supervision of a healthcare professional and is known for its efficacy in maintaining a consistent level of medication in the body.

• Long-acting injectable formulation
• Used for schizophrenia and schizoaffective disorder
• Administered monthly

• Active Ingredient Paliperidone
• Dosage 150 mg

Primarily used for the treatment of schizophrenia and schizoaffective disorder.

Patients diagnosed with schizophrenia or schizoaffective disorder.

Invega Sustenna is a product of Janssen Pharmaceuticals, a leader in the field of mental health medications. Known for their innovative solutions, Janssen has been at the forefront of developing treatments that improve the quality of life for individuals with mental health conditions.